Back to top
more

Centene (CNC)

(Delayed Data from NYSE)

$69.84 USD

69.84
2,921,881

+0.03 (0.04%)

Updated Jun 10, 2024 04:00 PM ET

After-Market: $69.82 -0.02 (-0.03%) 6:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 248)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for CNC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Centene Corporation [CNC]

Reports for Purchase

Showing records 521 - 540 ( 543 total )

Company: Centene Corporation

Industry: Medical - HMOs

Record: 521

04/26/2011

Company Report

Pages: 7

Delays $0.07 MS Recognition Pending CMS Approval

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 522

04/26/2011

Company Report

Pages: 14

Guidance Boost Reads as Conservatve

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 523

04/11/2011

Company Report

Pages: 7

Raising Price Target to $37 from $31 in Connection with 1Q11 Preview Based on Confidence in the Company''s Claims Clarity and Continued

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 524

03/25/2011

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of March 27

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 525

03/08/2011

Daily Note

Pages: 4

FL Medicaid Expansion Proposal Introduced in the Senate; Includes ABD/LTC, 90% Minimum MLR, and Member Cost Sharing

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 526

02/18/2011

Industry Report

Pages: 5

GA RFP Delayed at Least 1 Yr; ABD Still a Possibility

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 527

02/08/2011

Company Report

Pages: 15

Lots of Moving Pieces But $0.20 Boost From New Contracts Demonstrates Growth Potential

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 528

01/14/2011

Daily Note

Pages: 32

4Q10 Preview: Positive 2011 Outlook for Managed Care; Reiterate UNH and HUM as Top Picks

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 529

12/23/2010

Industry Report

Pages: 9

Updating Estimates for Ohio Rates; Continue to see Further Upside Potential If Utilization Remains Moderate

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 530

12/23/2010

Daily Note

Pages: 9

Updating Estimates for Ohio Rates, Continue to see Further Upside Potential If Utilization Remains Moderate

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 531

12/17/2010

Company Report

Pages: 12

Low Risk to Remaining Rate Announcements; Continue to View Growth Opportunity as Undervalued.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 532

12/16/2010

Industry Report

Pages: 27

Modest Medicare Growth in December; Expect Strong January Growth to be Driven by Gains.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 533

10/27/2010

Company Report

Pages: 12

Recent Contract Awards Bolster 2011 Outlook; Growth Opportunity Undervalued

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 534

10/13/2010

Daily Note

Pages: 31

Health Care Services - Managed Care -3Q10 Preview: See Largest Upside Potential at Humana,

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 535

09/22/2010

Industry Report

Pages: 6

Medicare PDP Premiums Increased 3.3%; Above Industry Trend of 1.4% Decrease.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 536

08/18/2010

Industry Report

Pages: 7

Medicare PDP Benchmark Down 1.4% to $87.05, Below Historical Trend of 5% Increases

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 537

07/27/2010

Company Report

Pages: 6

$0.03 Beat and $0.03-$0.05 Raise on Lower MLR Guidance; Positive Rate Outlook for GA, FL, and TX

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 538

07/26/2010

Daily Note

Pages: 16

2Q10 Preview: Healthcare Reform Likely to Overshadow Positive Fundamentals

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 539

06/23/2010

Company Report

Pages: 10

Long-Term Growth Potential Undervalued; HC Reform Could Add $0.96-1.10EPS, FMAP Update.

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Centene Corporation

Industry: Medical - HMOs

Record: 540

05/27/2010

Industry Report

Pages: 15

County Level Roll Up Analysis Shows Impact of Medicare Rate Regulations to Be More Material Than Originally Anticipated

Provider: WEDBUSH SECURITIES INC.

Price: 50.00

Research Provided by a Third Party